Is Zepbound FDA-approved?

FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity (November 2023)

How much does Zepbound cost?

Zepbound costs vary significantly by provider and form. Brand-name versions can cost $1,000–$1,600/month without insurance. Compounded versions from telehealth providers typically range from $129–$400/month. See the cost comparison table above for current prices from top providers. Always check for manufacturer savings programs or telehealth promo codes.

Where can I get Zepbound?

Zepbound requires a prescription from a licensed healthcare provider. You can get it through your primary care doctor, endocrinologist, or a telehealth platform. Telehealth providers like those listed above typically offer faster access and lower out-of-pocket costs than traditional pharmacies for compounded versions.

✅FDA Reviewed📅Updated April 6, 2026

Zepbound Guide

Zepbound is the brand-name formulation of tirzepatide 2.5–15mg specifically FDA-approved for chronic weight management, launched by Eli Lilly in late 2023. It is chemically identical to Mounjaro but approved specifically for obesity treatment, making it eligible for different insurance coverage pathways and savings programs.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

At a Glance

Generic Name	Tirzepatide
Brand Names	Zepbound
FDA Status	FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity (November 2023)
Approval Date	November 8, 2023

How Zepbound Works

Zepbound works through tirzepatide's dual GIP/GLP-1 mechanism to reduce appetite through both central brain signals and peripheral metabolic effects. GLP-1 activation creates feelings of fullness and slows digestion; GIP activation may additionally enhance fat metabolism and energy expenditure. This twin-hormone approach produces more weight loss than any single-pathway agent.

Dosing Schedule

Zepbound uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance.

Weeks 1–42.5mg/week

Weeks 5–85mg/week

Weeks 9–127.5mg/week

Weeks 13–1610mg/week

Weeks 17–2012.5mg/week

Week 21+15mg/week (maintenance)

Side Effects

Common: nausea (31%), diarrhea (23%), vomiting (13%), constipation (12%), abdominal pain (9%), injection site redness. Nausea is most common during dose escalation and typically resolves within a month of each new dose. Serious (rare): pancreatitis, cholelithiasis (gallstones), suicidal ideation monitoring recommended, thyroid tumor risk noted in animal models.

This is not a complete list. Consult your healthcare provider or prescriber for full safety information.

Clinical Trial Results

In the SURMOUNT-1 trial, Zepbound (tirzepatide 15mg) produced an average weight loss of 22.5% (about 52 lbs) over 72 weeks — the highest of any anti-obesity medication ever studied. At 10mg, participants lost 21.4%; at 5mg, they lost 15.0%. 91% of participants lost at least 5% of body weight at the 15mg dose.
Source: Published clinical trial data (STEP / SURMOUNT trial series)

Where to Get Zepbound

These telehealth providers offer access to tirzepatide or compounded equivalents with online consultations and home delivery.

CoreAge Rx

Best for: best overall value

9.0

★★★★★4.7 (850)

$149/mo

CompoundedFree 2-Day Shipping24/7 SupportLegitScript Verified

Get Started